grey arrow to go to previous Omnicell webpage or forward to next Omnicell pageBack to Press Release

July 20, 2016

Henry Mayo Newhall Hospital Selects Omnicell Medication Automation to Improve Nursing Workflows and Patient Safety

Download PDF

MOUNTAIN VIEW, Calif., July 20, 2016 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) today announced that Henry Mayo Newhall Hospital ("Henry Mayo") has selected the Company's medication automation solutions to streamline provider workflows and enhance patient care at its facility in Valencia, Calif. As construction begins on the hospital's new patient tower—which is expected to add over 140 patient beds—nursing and pharmacy leadership chose to update Henry Mayo's medication automation solutions to ensure the highest level of safety for patients.

Omnicell, Inc. logo.

The new Omnicell technology, including automated medication dispensing cabinets, is expected to help nurses at Henry Mayo spend more time with their patients. The Omnicell cabinets include a system that enables nurses to queue up medication orders at patients' bedsides rather than having to wait in line at the cabinet. Additionally, a single-dose dispensing system incorporated into the cabinets improves security and virtually eliminates the need for manual narcotic count-backs, which saves time that can now be spent on patient-facing activities. The greater capacity of the Omnicell cabinets compared with the hospital's current system will allow more medications to be securely stored at the nursing units, reducing the number of pharmacy deliveries.

The hospital will also be adding an automated dispensing cabinet tailored to the operating room and anesthesia provider workflow. Heightened security in this area, where many powerful narcotics are used, is essential to improving patient safety and reducing drug diversion risk. While these specialized cabinets provide security, they also provide convenient access to medications needed during surgical procedures.

"As we looked for a solution that increased the security of our medications in the OR and on the patient floors, we also wanted tools that helped streamline the distribution process for our nurses," said Harry Shamamian, PharmD, MBA, director of pharmacy services, Henry Mayo Newhall Hospital. "Omnicell's solutions offer both the security and flexibility we require while helping to expand the total medication capacity that our nurses need."

"We are pleased to partner with Henry Mayo, which has been recognized as one of the nation's 'Most Wired' hospitals for four consecutive years," said J. Christopher Drew, president, North American Automation and Analytics for Omnicell. "As this facility continues to grow, we look forward to offering additional solutions that will help maintain excellent patient safety and provider satisfaction while ensuring medication security across the hospital."

About Henry Mayo

Henry Mayo Newhall Hospital is a 238-bed not-for-profit acute care hospital serving the Santa Clarita Valley since 1975. Henry Mayo is an Advanced Primary Stroke Center and a Heart Attack Receiving Center. The hospital features state-of-the-art Inpatient facilities, a Neonatal Intensive Care Unit, Catheterization Lab, Cardiac Rehab Center, Infusion Center, Breast Imaging Center and an Outpatient Surgery Center. Additional services include cardiovascular, trauma, emergency, intensive care, neonatal intensive care, maternity, surgery, nursing, wound care, spine and joint, behavioral health, and acute rehab, as well as cancer, imaging, lab, digestive, respiratory services, and physical and occupational therapies. For more information, visit or call (661) 200-2000.

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been creating innovative solutions to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software for medication and supply management across the entire health care continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.

Over 4,000 customers worldwide use Omnicell automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety. The recent acquisition of Aesynt adds distinct capabilities, particularly in central pharmacy and IV robotics, creating the broadest medication management product portfolio in the industry.

The Omnicell SureMed solution provides innovative medication adherence packaging to help reduce costly hospital readmissions. In addition, these solutions enable approximately 7,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.

For more information about Omnicell, Inc. please visit


Editor's Notes:

  1. All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website,
  2. Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
  3. All other brand or product names may be trademarks or registered trademarks of their respective companies.

Logo -

To view the original version on PR Newswire, visit:

SOURCE Omnicell, Inc.

News Provided by Acquire Media